# Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds

Study · id `cardio:ct-nct05589454` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05589454](<https://clinicaltrials.gov/study/NCT05589454>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05589454

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 344 participants.

## Technical summary

Registry record NCT05589454. Randomized; no masking; primary purpose prevention. Start 2023-01 (anticipated); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 344 participants (planned count; ClinicalTrials.gov record NCT05589454, source copy `cardio:ctgov-nct05589454-2022-10-21`, retrieved 2026-10-26)
- Planned start: 2023-01 (anticipated) (ClinicalTrials.gov record NCT05589454, source copy `cardio:ctgov-nct05589454-2022-10-21`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT05589454, source copy `cardio:ctgov-nct05589454-2022-10-21`, retrieved 2026-10-26)
- Completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT05589454, source copy `cardio:ctgov-nct05589454-2022-10-21`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05589454, source copy `cardio:ctgov-nct05589454-2022-10-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05589454-2022-10-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
- Condition: Acute Ischemic Stroke
- Condition: Cerebral Microbleeds
- Intervention (Drug): Atorvastatin Calcium tablets 80mg
- Intervention (Drug): Atorvastatin Calcium tablets 20mg
- Lead sponsor: Sichuan Provincial People's Hospital
- Lead sponsor class: OTHER
- Collaborator: Science and Technology Department of Sichuan Province
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Sichuan Provincial People's Hospital (`cardio:org-sichuan-provincial-people-s-hospital`)

## Provenance

Content hash: 757b9b3396806ed51ca3a7b222e15f682c97990decbfee1788a1c714ad794abe
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
